Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct;74(10):592-603.
doi: 10.1111/pin.13474. Epub 2024 Aug 28.

Breast cancer during pregnancy of Luminal A type overexpressed CXCL13

Fumi Nozaki  1 , Yoko Nakanishi  1 , Tomoyuki Tanino  1 , Tomohiro Ochi  2 , Reika In  2   3 , Yuka Kajiura  2 , Kumiko Kida  2 , Junko Takei  2 , Atsushi Yoshida  2 , Naoki Kanomata  4 , Atsuko Kitano  5 , Hideko Yamauchi  2 , Shinobu Masuda  1
Affiliations

Breast cancer during pregnancy of Luminal A type overexpressed CXCL13

Fumi Nozaki et al. Pathol Int. 2024 Oct.

Abstract

Pregnancy-associated breast cancer has been increasing. In this study, we analyzed patients with breast cancer that occurred during pregnancy (PrBC) and compared their genetic profiles with those of patients with breast cancer that did not occur during pregnancy, within 1 year after childbirth nor during lactation (non-PrBC). We performed gene expression analyses of patients with PrBC and non-PrBC using microarrays and qRT-PCR. Microarray analysis showed that 355 genes were upregulated in the luminal-type PrBC group compared to those in the non-PrBC group. The C-X-C motif chemokine ligand 13 (CXCL13) gene was the most upregulated in the PrBC group compared to that in the non-PrBC group, especially in the luminal A-type (p = 0.016). This result was corroborated by the qRT-PCR analysis of microdissected cancer cells (p < 0.001). A negative correlation was observed between CXCL13 and estrogen receptor 1 (ESR1) mRNA expression levels in luminal A-type breast carcinoma (p < 0.001). Our results provide clues for a better understanding of breast cancer pathogenesis during pregnancy.

Keywords: CXCL13; breast cancer; breast cancer during pregnancy (PrBC); pregnancy; pregnancy‐associated breast cancer (PABC).

PubMed Disclaimer

References

REFERENCES

    1. Lethaby AE, O'Neill MA, Mason BH, Holdaway IM, Harvey VJ. Overall survival from breast cancer in women pregnant or lactating at or after diagnosis. Int J Cancer. 1996;67:751–755.
    1. Amant F, Lefrère H, Borges VF, Cardonick E, Lambertini M, Loibl S, et al. The definition of pregnancy‐associated breast cancer is outdated and should no longer be used. Lancet Oncol. 2021;22:753–754.
    1. Ishida T, Yokoe T, Kasumi F, Sakamoto G, Makita M, Tominaga T, et al. Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case‐control study in Japan. Jpn J Cancer Res. 1992;83:1143–1149.
    1. Makita M, Sakamoto G, Namba K, Akiyama F, Iwase T, Sugano H, et al. Study of breast cancers during pregnancy and lactation. Jap J of Can Clin. 1990;36:39–44.
    1. Amant F, von Minckwitz G, Han SN, Bontenbal M, Ring AE, Giermek J, et al. Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. J Clin Oncol. 2013;31:2532–2539.

MeSH terms

LinkOut - more resources